Xeris Biopharma Holdings XERS
NASDAQ XERS
$10.86 +0.08 (+0.74%)
As of: Oct 22, 2026 · 10:12 AM EDT

Xeris Biopharma Holdings (XERS) EV to EBITDA (2025 - 2026)

Updated

Xeris Biopharma Holdings' EV to EBITDA came in at 25.69 for Q2 2026, down 91.6% from 304.09 a year earlier but up 39.0% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) EV to EBITDA (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Xeris Biopharma Holdings reported EV to EBITDA of 19.25, down 91.1% year-over-year; for FY2025, it came in at 32.22.

  • The five-year range for quarterly EV to EBITDA is 18.49 (Q1 2026) to 304.09 (Q2 2025).
  • Business Quant data shows XERS's EV to EBITDA at 18.49 (Q1 2026), 32.22 (Q4 2025) and 57.25 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,164.86 Bn 1,133.45 Bn 19.71 Bn
2 Johnson & Johnson 632.18 Bn 550.71 Bn 17.26 Bn
3 AbbVie 503.53 Bn 476.64 Bn 12.70 Bn
4 Merck 378.03 Bn 332.41 Bn 12.21 Bn
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn
6 Astrazeneca 266.38 Bn 240.07 Bn 12.86 Bn
7 Amgen 241.24 Bn 196.64 Bn 7.24 Bn
8 Gilead Sciences 193.68 Bn 167.88 Bn 6.22 Bn
9 Pfizer 172.22 Bn 118.87 Bn 10.94 Bn
10 Xeris Biopharma Holdings 1.88 Bn 1.44 Bn 79.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.98
Mar 31, 2026 17.27
Dec 31, 2025 29.56
Sep 30, 2025 49.86
Jun 30, 2025 125.39
API Access

Xeris Biopharma Holdings EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=XERS&period=max&api_key=YOUR_API_KEY